For: | Mohamed IN, Li L, Ismael S, Ishrat T, El-Remessy AB. Thioredoxin interacting protein, a key molecular switch between oxidative stress and sterile inflammation in cellular response. World J Diabetes 2021; 12(12): 1979-1999 [PMID: 35047114 DOI: 10.4239/wjd.v12.i12.1979] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v12/i12/1979.htm |
Number | Citing Articles |
1 |
Wan-Li Duan, Xue-Jie Wang, Ya-Ping Ma, Zhi-Mei Sheng, Hao Dong, Li-Ying Zhang, Bao-Gang Zhang, Mao-Tao He. Therapeutic strategies targeting the NLRP3‑mediated inflammatory response and pyroptosis in cerebral ischemia/reperfusion injury (Review). Molecular Medicine Reports 2024; 29(3) doi: 10.3892/mmr.2024.13170
|
2 |
Ramkumar Katturajan, Sangeetha Nithiyanandam, Manisha Parthasarathy, Abilash Valsala Gopalakrishnan, Ezhaveni Sathiyamoorthi, Jintae Lee, Thiyagarajan Ramesh, Mahalaxmi Iyer, Sabina Evan Prince, Raja Ganesan. Immunomodulatory Role of Thioredoxin Interacting Protein in Cancer’s Impediments: Current Understanding and Therapeutic Implications. Vaccines 2022; 10(11): 1902 doi: 10.3390/vaccines10111902
|
3 |
Jing Yi, Li Li, Zhu-jun Yin, Yun-yun Quan, Rui-rong Tan, Shi-long Chen, Ji-rui Lang, Jiao Li, Jin Zeng, Yong Li, Zi-jian Sun, Jun-ning Zhao. Polypeptide from Moschus Suppresses Lipopolysaccharide-Induced Inflammation by Inhibiting NF-κ B-ROS/NLRP3 Pathway. Chinese Journal of Integrative Medicine 2023; 29(10): 895 doi: 10.1007/s11655-023-3598-z
|
4 |
Kyriazoula Chatzianagnostou, Melania Gaggini, Adrian Suman Florentin, Ludovica Simonini, Cristina Vassalle. New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions. International Journal of Molecular Sciences 2024; 25(11): 6218 doi: 10.3390/ijms25116218
|
5 |
Qiyou Ding, Zezheng Gao, Keyu Chen, Qiqi Zhang, Shiwan Hu, Linhua Zhao. Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.883410
|
6 |
Wenchao Xu, Hailan Wang, Qian Sun, Tianqi Hua, Jun Bai, Qingbi Zhang, Qizhan Liu, Xinye Ni. TXNIP‐NLRP3‐GSDMD axis‐mediated inflammation and pyroptosis of islet β‐cells is involved in cigarette smoke‐induced hyperglycemia, which is alleviated by andrographolide. Environmental Toxicology 2024; 39(3): 1415 doi: 10.1002/tox.24046
|
7 |
Yuqi Wen, Yang Liu, Weihong Liu, Wenli Liu, Jinyan Dong, Qingkuo Liu, Hao Hao, Hongsheng Ren. Research progress on the activation mechanism of NLRP3 inflammasome in septic cardiomyopathy. Immunity, Inflammation and Disease 2023; 11(10) doi: 10.1002/iid3.1039
|
8 |
S. Klimczak, A. Śliwińska. Epigenetic regulation of inflammation in insulin resistance. Seminars in Cell & Developmental Biology 2024; 154: 185 doi: 10.1016/j.semcdb.2022.09.004
|
9 |
Yanyan Xiao, Chenglin Yang, Nana Si, Tao Chu, Jiahui Yu, Xintong Yuan, Xiang-Tao Chen. Epigallocatechin-3-gallate Inhibits LPS/AβO-induced Neuroinflammation in BV2 Cells through Regulating the ROS/TXNIP/NLRP3 Pathway. Journal of Neuroimmune Pharmacology 2024; 19(1) doi: 10.1007/s11481-024-10131-z
|
10 |
T. I. Vitkina, E. V. Kondratyeva. Detection of chronic obstructive pulmonary disease biomarkers using ROC-analysis. Bulletin Physiology and Pathology of Respiration 2022; (85): 32 doi: 10.36604/1998-5029-2022-85-32-36
|